Biotechnology
BreakSight is a biotech startup focused on identifying DNA break signatures and patterns caused by DNA-damaging drugs and enabling the discovery of novel DNA sequence biomarkers that may further predict response to targeted cancer therapies. Through our streamlined service platform, we aim to impact precision medicine by expanding the range and use of DNA sequences across the genome with therapeutic potential for academic institutions, biotech, and Pharma companies.